In a significant step toward streamlining India's medical device regulatory ecosystem, the Central Drugs Standard Control ...
CDSCO releases MedTech Mitra's handbook for innovators in IVD medical devices segment: Our Bureau, New Delhi Wednesday, December 10, 2025, 08:00 Hrs [IST] The Central Drugs Standa ...
CDSCO launches new online risk classification module for medical devices to simplify approval procedures: Gireesh Babu, New Delhi Tuesday, December 9, 2025, 08:00 Hrs [IST] The Ce ...
In recent years, the in vitro diagnostics (IVD) regulatory landscape in Europe has changed and we are now in the transition from IVD Directive 98/79/EC (IVDD) to In Vitro Medical Devices Regulation ...
IVD Contract Manufacturing Services Market Overview: The global IVD contract manufacturing services market is projected to grow at a CAGR of roughly 11% over the forecast period. This expansion is ...
Leveraging the profound legacy of Lords Mark Industries, a powerhouse with 25 years of excellence in Security paper, solar & ...
PT Fapon Bioindustries Indonesia (referred to as "PT Fapon") and the Indonesian state-owned pharmaceutical holding company PT ...
A stronger domestic industry will not just boost the local industry and reduce the import bill but also ensure that ...
Medical Device Network on MSN
Cleveland Diagnostics’ IsoPSA secures FDA approval for prostate cancer
The decision is supported by evidence from a clinical study and data from supporting analytical validation trials.
Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.
ImpriMed, a precision oncology CRO specializing in ex vivo drug sensitivity testing for hematologic malignancies, announced today that it has been selected to present two significant research studies ...
BoomRx, a fast-growing national pharmaceutical technology platform launched in July with more than 1,000 provider signups to date, is bringing its centralized ordering platform directly to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results